Vicente Vicente

Q: What Schools Are Affiliated With Vicente Vicente

Vicente Vicente is affiliated with the following schools: MD Anderson Cancer Center, University of Murcia, University of Salamanca, University of Cambridge

Vicente Vicente's AcademicInfluence.com Rankings

Vicente Vicente

Philosophy

#8847

World Rank

#12304

Historical Rank

Logic

#5860

World Rank

#7305

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Vicente Vicente's Degrees

Bachelors Medicine University of Salamanca

Why Is Vicente Vicente Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Vicente Vicente's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Platelet receptors and signaling in the dynamics of thrombus formation (2009) (376)
Recognition of distinct adhesive sites on fibrinogen by related integrins on platelets and endothelial cells (1989) (329)
[Bernard -Soulier syndrome]. (1992) (266)
Observation versus antiplatelet therapy as primary prophylaxis for thrombosis in low-risk essential thrombocythemia. (2010) (205)
Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation (2013) (201)
Genome-wide association study identifies a sequence variant within the DAB2IP gene conferring susceptibility to abdominal aortic aneurysm (2010) (197)
Tumor-infiltrating immune cell profiles and their change after neoadjuvant chemotherapy predict response and prognosis of breast cancer (2014) (196)
Assessment and prognostic value of the European LeukemiaNet criteria for clinicohematologic response, resistance, and intolerance to hydroxyurea in polycythemia vera. (2012) (193)
Polymorphisms of platelet membrane glycoprotein Ib associated with arterial thrombotic disease. (1998) (187)
Predictive value of the HAS-BLED and ATRIA bleeding scores for the risk of serious bleeding in a "real-world" population with atrial fibrillation receiving anticoagulant therapy. (2013) (186)
The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation. (2013) (184)
Food and Chemical Toxicology (2013) (184)
Flavonoids inhibit platelet function through binding to the thromboxane A2 receptor (2005) (176)
Identification of a site in the alpha chain of platelet glycoprotein Ib that participates in von Willebrand factor binding. (1990) (174)
Cytotoxicity and Antiproliferative Activities of Several Phenolic Compounds Against Three Melanocytes Cell Lines: Relationship Between Structure and Activity (2004) (160)
Controlled trial of desmopressin in liver cirrhosis and other conditions associated with a prolonged bleeding time (1986) (149)
Rosmarinic acid, a photo-protective agent against UV and other ionizing radiations. (2009) (137)
Incidence and clinical characteristics of hereditary disorders associated with venous thrombosis (1991) (134)
Relation of the HAS-BLED Bleeding Risk Score to Major Bleeding, Cardiovascular Events, and Mortality in Anticoagulated Patients With Atrial Fibrillation (2012) (131)
Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients. (2011) (130)
SAMe-TT2R2 score, time in therapeutic range, and outcomes in anticoagulated patients with atrial fibrillation. (2014) (127)
The FXIII Val34Leu polymorphism in venous and arterial thromboembolism. (2000) (124)
Renal impairment in a "real-life" cohort of anticoagulated patients with atrial fibrillation (implications for thromboembolism and bleeding). (2013) (114)
The venous thrombosis risk factor 20210 A allele of the prothrombin gene is not a major risk factor for arterial thrombotic disease (1997) (107)
Antithrombin Cambridge II (A384S): an underestimated genetic risk factor for venous thrombosis. (2007) (104)
Identification of miRNAs as potential modulators of tissue factor expression in patients with systemic lupus erythematosus and antiphospholipid syndrome (2011) (103)
Contribution of factor VII genotype to activated FVII levels. Differences in genotype frequencies between northern and southern European populations. (1997) (101)
High sensitivity cardiac troponin T and interleukin‐6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation (2012) (101)
Nonsense mutation in the glycoprotein Ib alpha coding sequence associated with Bernard-Soulier syndrome. (1990) (99)
A multimarker risk stratification approach to non‐ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro‐BNP and fibrin D‐dimer levels (2007) (97)
Role of the 807 C/T Polymorphism of the α2 Gene in Platelet GP Ia Collagen Receptor Expression and Function (1999) (95)
Thrombophilia testing in patients with venous thromboembolism. Findings from the RIETE registry. (2009) (87)
Pharmacogenetic relevance of CYP4F2 V433M polymorphism on acenocoumarol therapy. (2009) (86)
Polymorphisms of clotting factors modify the risk for primary intracranial hemorrhage. (2001) (86)
Intravenous and Subcutaneous Administration of Desmopresssin (DDAVP) to Hemophiliacs: Pharmacokinetics and Factor VIII Responses (1987) (86)
Introducing high-throughput sequencing into mainstream genetic diagnosis practice in inherited platelet disorders (2017) (86)
Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy. (2008) (85)
Controlled trial of desmopressin in liver cirrhosis and other conditions associated with a prolonged bleeding time. (1986) (83)
A common polymorphism in the annexin V Kozak sequence (-1C>T) increases translation efficiency and plasma levels of annexin V, and decreases the risk of myocardial infarction in young patients. (2002) (82)
Apigenin inhibits platelet adhesion and thrombus formation and synergizes with aspirin in the suppression of the arachidonic acid pathway. (2008) (81)
Effects of several flavonoids on the growth of B16F10 and SK-MEL-1 melanoma cell lines : relationship between structure and activity (2002) (79)
Isolation and functional characterization of the von Willebrand factor-binding domain located between residues His1-Arg293 of the alpha-chain of glycoprotein Ib. (1988) (78)
Flavonoids inhibit the platelet TxA(2) signalling pathway and antagonize TxA(2) receptors (TP) in platelets and smooth muscle cells. (2007) (78)
Determination of plasma protein C inhibitor and of two activated protein C-inhibitor complexes in normals and in patients with intravascular coagulation and thrombotic disease. (1990) (77)
Beneficial action of Citrus flavonoids on multiple cancer-related biological pathways. (2007) (75)
Prognostic evaluation of febrile neutropenia in apparently stable adult cancer patients (2011) (71)
A nonsense polymorphism in the protein Z-dependent protease inhibitor increases the risk for venous thrombosis. (2006) (66)
Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients (2017) (65)
Busulfan in patients with polycythemia vera or essential thrombocythemia refractory or intolerant to hydroxyurea (2014) (64)
Novel mutations in RASGRP2, which encodes CalDAG-GEFI, abrogate Rap1 activation, causing platelet dysfunction. (2016) (64)
Variant Bernard-Soulier syndrome type bolzano. A congenital bleeding disorder due to a structural and functional abnormality of the platelet glycoprotein Ib-IX complex. (1990) (64)
Mutations in the shutter region of antithrombin result in formation of disulfide‐linked dimers and severe venous thrombosis (2004) (64)
Hereditary thrombophilia: identification of nonsense and missense mutations in the protein C gene. (1987) (62)
Loss of high‐affinity thrombin receptors during platelet concentrate storage impairs the reactivity of platelets to thrombin (1997) (61)
Effects of exogenous melatonin and circadian synchronization on tumor progression in melanoma‐bearing C57BL6 mice (2008) (61)
Role of Fibrinogen Levels and Factor XIII V34L Polymorphism in Thrombolytic Therapy in Stroke Patients (2006) (60)
Protein Z/Z‐dependent protease inhibitor (PZ/ZPI) anticoagulant system and thrombosis (2007) (60)
The genetics of antithrombin. (2018) (60)
Towards the targeted management of Chediak-Higashi syndrome (2014) (58)
A Common Polymorphism Flanking the ATG Initiator Codon of GPIbα Does not Affect Expression and Is not a Major Risk Factor for Arterial Thrombosis (2000) (58)
The SAMe-TT2R2 Score Predicts Poor Anticoagulation Control in AF Patients: A Prospective 'Real-world' Inception Cohort Study. (2015) (57)
Adjuvant therapy with bemiparin in patients with limited-stage small cell lung cancer: results from the ABEL study. (2013) (57)
Clinical features and short-term outcomes of cancer patients with suspected and unsuspected pulmonary embolism: the EPIPHANY study (2017) (54)
Evaluation of four rapid methods for hemoglobin screening of whole blood donors in mobile collection settings. (2007) (54)
Supportive management strategies for disseminated intravascular coagulation (2015) (54)
HPA-1 genotype in arterial thrombosis--role of HPA-1b polymorphism in platelet function. (1997) (54)
Angiogenic role of miR-20a in breast cancer (2018) (54)
Quantification of Circulating Activated Protein C in Human Plasma by Immunoassays - Enzyme Levels are Proportional to Total Protein C Levels (1996) (53)
The prothrombin gene variant 20210A in venous and arterial thromboembolism. (1999) (52)
Thromboxane A2 receptor antagonism by flavonoids: structure-activity relationships. (2009) (52)
Peritoneal fluid modifies the microRNA expression profile in endometrial and endometriotic cells from women with endometriosis. (2015) (51)
Clinical and genetic determinants of anthracycline-induced cardiac iron accumulation. (2012) (50)
Subcutaneous Desmopressin (DDAVP) Shortens the Prolonged Bleeding Time in Patients with Liver Cirrhosis (1990) (50)
The number of platelet glycoprotein Ia molecules is associated with the genetically linked 807 C/T and HPA‐5 polymorphisms (1999) (50)
In silico discovery of a compound with nanomolar affinity to antithrombin causing partial activation and increased heparin affinity. (2012) (49)
Association of anthracycline-related cardiac histological lesions with NADPH oxidase functional polymorphisms. (2013) (48)
L-asparaginase-induced antithrombin type I deficiency: implications for conformational diseases. (2006) (48)
Detection of Factor V Leiden from a Drop of Blood by PCR-SSCP (1996) (48)
Biallelic Mutations in KDSR Disrupt Ceramide Synthesis and Result in a Spectrum of Keratinization Disorders Associated with Thrombocytopenia (2017) (47)
Plasma angiogenin levels in acute coronary syndromes: implications for prognosis. (2007) (44)
Long‐Term Stroke Risk Prediction in Patients With Atrial Fibrillation: Comparison of the ABC‐Stroke and CHA 2 DS 2‐VASc Scores (2017) (44)
MiR-146a Regulates Neutrophil Extracellular Trap Formation That Predicts Adverse Cardiovascular Events in Patients With Atrial Fibrillation (2018) (43)
Homozygous Deficiency of Heparin Cofactor II: Relevance of P17 Glutamate Residue in Serpins, Relationship With Conformational Diseases, and Role in Thrombosis (2004) (43)
Prothrombin A19911G and G20210A polymorphisms' role in thrombosis (2002) (43)
Usefulness of N-Terminal Pro–B-Type Natriuretic Peptide Levels for Stroke Risk Prediction in Anticoagulated Patients With Atrial Fibrillation (2014) (42)
Genetic polymorphisms of factor VII are not associated with arterial thrombosis (1998) (42)
Factor XIII Val34Leu polymorphism modulates the prothrombotic and inflammatory state associated with atrial fibrillation. (2004) (42)
The association of the beta1-tubulin Q43P polymorphism with intracerebral hemorrhage in men. (2007) (41)
Migraine and Prothrombotic Genetic Risk Factors (1998) (41)
Predicting serious complications in patients with cancer and pulmonary embolism using decision tree modelling: the EPIPHANY Index (2017) (41)
Liposoluble antioxidants provide an effective radioprotective barrier. (2009) (41)
Antithrombin Cambridge II (A384S) supports a role for antithrombin deficiency in arterial thrombosis (2009) (40)
Congenital Deficiency of Vitamin K-Dependent Coagulation Factors and Protein C (1984) (40)
Binding of Recombinant Apolipoprotein(a) to Human Platelets and Effect on Platelet Aggregation (2001) (40)
Refining Stroke and Bleeding Prediction in Atrial Fibrillation by Adding Consecutive Biomarkers to Clinical Risk Scores. (2019) (40)
Predictive value of the CHA2DS2-VASc score in atrial fibrillation patients at high risk for stroke despite oral anticoagulation. (2012) (40)
Role of lipopolysaccharide and cecal ligation and puncture on blood coagulation and inflammation in sensitive and resistant mice models. (2005) (39)
Differential effects of quercetin, apigenin and genistein on signalling pathways of protease‐activated receptors PAR1 and PAR4 in platelets (2009) (39)
Long-term bleeding risk prediction in ‘real world’ patients with atrial fibrillation: Comparison of the HAS-BLED and ABC-Bleeding risk scores (2017) (39)
Effect of citrullination on the function and conformation of antithrombin (2009) (39)
The effect of the flavonoid diosmin, grape seed extract and red wine on the pulmonary metastatic B16F10 melanoma. (2005) (38)
The genetic interaction between VKORC1 c1173t and calumenin a29809g modulates the anticoagulant response of acenocoumarol (2007) (38)
miR-133a Regulates Vitamin K 2,3-Epoxide Reductase Complex Subunit 1 (VKORC1), a Key Protein in the Vitamin K Cycle (2012) (37)
Thrombosis as a conformational disease. (2005) (37)
Effects of several polyhydroxylated flavonoids on the growth of B16F10 melanoma and Melan-a melanocyte cell lines: influence of the sequential oxidation state of the flavonoid skeleton (2003) (37)
Amelioration of the severity of heparin-binding antithrombin mutations by posttranslational mosaicism. (2012) (37)
Hypoglycosylation is a common finding in antithrombin deficiency in the absence of a SERPINC1 gene defect (2016) (37)
Does von Willebrand factor improve the predictive ability of current risk stratification scores in patients with atrial fibrillation? (2017) (37)
Prognostic role of MIR146A polymorphisms for cardiovascular events in atrial fibrillation (2014) (36)
The effects of radiofrequency on skin: Experimental study (2008) (36)
The influence of riboflavin photochemistry on plasma coagulation factors. (2009) (36)
Stability of Glycoproteins Ib/IX and IIb/IIIa during Preparation and Storage of Platelet Concentrates: Detection by Binding Assays with Epitope‐Defined Monoclonal Antibodies and Physiological Ligands (1994) (36)
Application of a new enzyme‐linked immunosorbent assay for detection of total hepatitis C virus core antigen in blood donors (2003) (35)
Prothrombotic Genetic Risk Factors in Patients With Coexisting Migraine and Ischemic Cerebrovascular Disease (1999) (35)
L718P mutation in the membrane-proximal cytoplasmic tail of β3 promotes abnormal αIIbβ3 clustering and lipid microdomain coalescence, and associates with a thrombasthenia-like phenotype (2010) (35)
Platelet septin complexes form rings and associate with the microtubular network (2006) (35)
Incidence of increased plasminogen activator inhibitor in patients with deep venous thrombosis and/or pulmonary embolism. (1989) (35)
Potential Role of miRNAs in Developmental Haemostasis (2011) (35)
Risk of thrombosis during pregnancy and post‐partum in hereditary thrombophilia (1994) (35)
Comparison of estimated glomerular filtration rate equations for dosing new oral anticoagulants in patients with atrial fibrillation. (2015) (34)
Functional consequences of the prothrombotic SERPINC1 rs2227589 polymorphism on antithrombin levels (2009) (34)
Normal pregnancy in a patient with a postpartum factor VIII inhibitor (1987) (34)
The role of the spleen in regulating the plasma levels of factor VIII--von Willebrand's factor after DDAVP. (1982) (34)
Regulation of Coagulation Factor XI Expression by MicroRNAs in the Human Liver (2014) (34)
Coagulation abnormalities in patients with Mediterranean spotted fever. (1986) (34)
Activation of the protein C pathway in acute sepsis. (1995) (33)
AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms (2008) (33)
Plasminogen activator inhibitor-1 levels in severe and morbid obesity. Effect of weight loss and influence of 4G/5G polymorphism. (2008) (33)
The TFPI 536C →T Mutation Is not Associated with Increased Risk for Venous or Arterial Thrombosis (2000) (33)
Clinical and analytical relevance of the combination of prothrombin 20210A/A and factor V Leiden: results from a large family (1999) (33)
Evidence of activation of the protein C pathway during acute vascular damage induced by Mediterranean spotted fever. (1991) (31)
A pharmacogenetic effect of factor XIII valine 34 leucine polymorphism on fibrinolytic therapy for acute myocardial infarction. (2005) (31)
Protein C levels in late pregnancy, postpartum and in women on oral contraceptives. (1985) (31)
miR-146a is a pivotal regulator of neutrophil extracellular trap formation promoting thrombosis (2020) (31)
Multirefractory primary immune thrombocytopenia; targeting the decreased sialic acid content (2018) (31)
Novel loci involved in platelet function and platelet count identified by a genome-wide study performed in children (2011) (30)
Predicting Adverse Events beyond Stroke and Bleeding with the ABC-Stroke and ABC-Bleeding Scores in Patients with Atrial Fibrillation: The Murcia AF Project (2020) (30)
Antithrombin Murcia (K241E) causing antithrombin deficiency: a possible role for altered glycosylation (2010) (30)
Biological dosimetry and Bayesian analysis of chromosomal damage in thyroid cancer patients. (2007) (30)
Prospective Randomized Study Comparing the Efficacy of Bioequivalent Doses of glycosylated and nonglycosylated rG‐CSF for Mobilizing Peripheral Blood Progenitor Cells (1997) (30)
Association of the Thrombomodulin Gene c.1418C>T Polymorphism With Thrombomodulin Levels and With Venous Thrombosis Risk (2013) (30)
Effect of quercetin on platelet spreading on collagen and fibrinogen and on multiple platelet kinases. (2010) (30)
Platelet GP IIIa Polymorphism HPA-1 (PlA) Protects Against Subarachnoid Hemorrhage (2004) (29)
Delayed recovery and increased severity of Paclitaxel-induced peripheral neuropathy in patients with diabetes. (2015) (29)
Five prothrombotic polymorphisms and the prevalence of premature myocardial infarction. (2005) (28)
Natural anticoagulant proteins and antiphospholipid antibodies in systemic lupus erythematosus. (1998) (28)
Protein C Deficiency – Response to Danazol and DDAVP (1985) (28)
Identification of two novel mutations in RASGRP2 affecting platelet CalDAG-GEFI expression and function in patients with bleeding diathesis (2017) (28)
Regulatory regions of SERPINC1 gene: Identification of the first mutation associated with antithrombin deficiency (2012) (27)
Immune recovery after autologous or rhG‐CSF primed PBSC transplantation (1996) (27)
Cryopreservation Modifies Flow‐Cytometric Analysis of Hemopoietic Cells (1995) (27)
Management of antithrombin deficiency: an update for clinicians (2019) (27)
Functional and molecular characterization of inherited platelet disorders in the Iberian Peninsula: results from a collaborative study (2014) (27)
Clinical and biological impact of miR-18a expression in breast cancer after neoadjuvant chemotherapy (2019) (27)
Ankle brachial index as an independent predictor of mortality in anticoagulated atrial fibrillation (2012) (27)
Antithrombin controls tumor migration, invasion and angiogenesis by inhibition of enteropeptidase (2016) (26)
Synergistic association between hypercholesterolemia and the C46T factor XII polymorphism for developing premature myocardial infarction (2005) (26)
Prognostic value of thrombin generation parameters in hospitalized COVID-19 patients (2020) (26)
Reduced Time in Therapeutic Range and Higher Mortality in Atrial Fibrillation Patients Taking Acenocoumarol. (2018) (26)
Genetic Polymorphisms of Platelet Adhesive Molecules: Association with Breast Cancer Risk and Clinical Presentation (2003) (26)
Long-term bleeding risk prediction in 'real world' patients with atrial fibrillation: Comparison of the HAS-BLED and ABC-Bleeding risk scores. (2017) (25)
Quantitative defect of glycoprotein ib in severe cirrhotic patients (1994) (25)
Comprehensive comparison of neonate and adult human platelet transcriptomes (2017) (25)
Deep venous thrombosis or pulmonary embolism and factor V Leiden: enigma or paradox (2010) (25)
Role of factor XIII Val34Leu polymorphism in patients <45 years of age with acute myocardial infarction. (2003) (25)
Significant Hypo-Responsiveness to GPVI and CLEC-2 Agonists in Pre-Term and Full-Term Neonatal Platelets and following Immune Thrombocytopenia (2018) (24)
Chediak–Higashi syndrome: description of two novel homozygous missense mutations causing divergent clinical phenotype (2014) (24)
High levels of latent antithrombin in plasma from patients with antithrombin deficiency (2017) (24)
Reduced Effect of Exercise and DDAVP on Factor VIII-von Willebrand Factor and Plasminogen Activator after Sequential Application of Both the Stimuli (1984) (24)
Type II antithrombin deficiency caused by a large in‐frame insertion: structural, functional and pathological relevance (2012) (23)
Real-life management of primary immune thrombocytopenia (ITP) in adult patients and adherence to practice guidelines (2016) (23)
Enhancing the ‘real world’ prediction of cardiovascular events and major bleeding with the CHA2DS2-VASc and HAS-BLED scores using multiple biomarkers (2018) (23)
Evaluation of pooled platelet concentrates using prestorage versus poststorage WBC reduction: impact of filtration timing (2000) (23)
microRNAs in the haemostatic system: More than witnesses of thromboembolic diseases? (2018) (23)
A Propensity Score Matched Comparison of Clinical Outcomes in Atrial Fibrillation Patients Taking Vitamin K Antagonists: Comparing the “Real‐World” vs Clinical Trials (2018) (23)
Hermansky-Pudlak syndrome (2014) (23)
Protein C Inhibitor and Other Components of the Protein C Pathway in Patients with Acute Deep Vein Thrombosis during Heparin Treatment (1990) (22)
Polymorphisms of Platelet Adhesive Receptors: Do They Play a Role in Primary Intracerebral Hemorrhage? (2003) (22)
Effect of hemodialysis on protein C levels. (1987) (22)
Factors with conformational effects on haemostatic serpins: Implications in thrombosis (2007) (22)
Rare homozygous status of P43 β1-tubulin polymorphism causes alterations in platelet ultrastructure (2011) (22)
Inherited Platelet Disorders: An Updated Overview (2021) (21)
The prognostic role of the adiponectin levels in atrial fibrillation (2013) (21)
Puzzling questions on antithrombin: Diagnostic limitations and real incidence in venous and arterial thrombosis. (2015) (21)
Importance of time in therapeutic range on bleeding risk prediction using clinical risk scores in patients with atrial fibrillation (2017) (20)
Dose reduction of intraoral dental radiography in Spain. (2006) (20)
Short alleles of P-selectin glycoprotein ligand-1 protect against premature myocardial infarction. (2004) (20)
Increased levels of citrullinated antithrombin in plasma of patients with rheumatoid arthritis and colorectal adenocarcinoma determined by a newly developed ELISA using a specific monoclonal antibody (2010) (20)
Detection of conformational transformation of antithrombin in blood with crossed immunoelectrophoresis: new application for a classical method. (2003) (20)
Poly(ADP-ribose) polymerase-1 inhibition increases expression of heat shock proteins and attenuates heat stroke-induced liver injury (2008) (20)
Antithrombin Dublin (p.Val30Glu): a relatively common variant with moderate thrombosis risk of causing transient antithrombin deficiency (2016) (20)
Response of Factor VIII/Von Willebrand Factor to Intranasal DDAVP in Healthy Subjects and Mild Haemophiliacs (with Observations in Patients with Combined Deficiency of Factors V and VIII) (1982) (19)
CEREBROSPINAL FLUID LEVELS BETA2 MICROGLOBULIN AND FERRITIN IN LYMPHOPROLIVERATIVE DISORDERS (1982) (19)
High on-treatment platelet reactivity in patients with ischemic cerebrovascular disease: assessment of prevalence and stability over time using four platelet function tests (2014) (19)
Effect of Factor XIII VAL34LEU Polymorphism on Thrombolytic Therapy in Premature Myocardial Infarction (2002) (19)
Wiskott–Aldrich syndrome in a child presenting with macrothrombocytopenia (2017) (19)
Pharmacogenetics of acenocoumarol in patients with extreme dose requirements (2010) (19)
Estimated absolute effects on efficacy and safety outcomes of using non-vitamin K antagonist oral anticoagulants in 'real-world' atrial fibrillation patients: A comparison with optimally acenocoumarol anticoagulated patients. (2017) (19)
Effects of conventional neoadjuvant chemotherapy for breast cancer on tumor angiogenesis (2015) (19)
Autoaggression syndrome resembling acute graft-versus-host disease grade IV after autologous peripheral blood stem cell transplantation for breast cancer (1999) (18)
Dexamethasone induces a heat‐stress response that ameliorates the conformational consequences on antithrombin of l‐asparaginase treatment (2009) (18)
Impaired leucocyte activation is underlining the lower thrombotic risk of essential thrombocythaemia patients with CALR mutations as compared with those with the JAK2 mutation (2016) (18)
sST2 levels are associated with all‐cause mortality in anticoagulated patients with atrial fibrillation (2015) (18)
Synergistic effect of diosmin and interferon-alpha on metastatic pulmonary melanoma. (2009) (18)
New alleles of the platelet glycoprotein Ibalpha gene. (1998) (18)
Soluble Fibrin Monomer Complex and Prediction of Cardiovascular Events in Atrial Fibrillation: The Observational Murcia Atrial Fibrillation Project (2018) (18)
Latent and Polymeric Antithrombin: Clearance and Potential Thrombotic Risk (2007) (18)
Implications of pharmacogenetics for oral anticoagulants metabolism. (2009) (17)
On the necessity of new decision-making methods for cancer-associated, symptomatic, pulmonary embolism. (2016) (17)
Factor VII –323 decanucleotide D/I polymorphism in atrial fibrillation: Implications for the prothrombotic state and stroke risk (2008) (17)
Novel Associations of VKORC1 Variants with Higher Acenocoumarol Requirements (2013) (17)
Platelet cryopreservation using a reduced dimethyl sulfoxide concentration and second-messenger effectors as cryopreserving solution. (1999) (17)
Identification of Regulatory Mutations in SERPINC1 Affecting Vitamin D Response Elements Associated with Antithrombin Deficiency (2016) (17)
Impact of whole-body 18F-FDG PET on diagnostic and therapeutic management of Medical Oncology patients. (2008) (17)
Nonsense Mutation in Exon-19 of GPIIb Associated with Thrombasthenic Phenotype. Failure of GPIIb(Δ597-1008) to Form Stable Complexes with GPIIIa (2002) (17)
Usefulness of the 2MACE Score to Predicts Adverse Cardiovascular Events in Patients With Atrial Fibrillation. (2017) (16)
Evaluation of platelet function during extended storage in additive solution, prepared in a new container that allows manual buffy-coat platelet pooling and leucoreduction in the same system. (2012) (16)
Association of polymorphisms in TRAIL1 and TRAILR1 genes with susceptibility to lymphomas (2014) (16)
Neutrophil extracellular trap components increase the expression of coagulation factors. (2019) (16)
Protective role of antithrombin in mouse models of liver injury. (2012) (16)
Regulation of TFPIα expression by miR-27a/b-3p in human endothelial cells under normal conditions and in response to androgens (2017) (16)
MiRNA-Based Regulation of Hemostatic Factors through Hepatic Nuclear Factor-4 Alpha (2016) (15)
Persistent cytotoxic T lymphocyte expansions after allogeneic haematopoietic stem cell transplantation: kinetics, clinical impact and absence of STAT3 mutations (2016) (15)
Experimental model of pulmonary metastasis treatment with IFNalpha. (2005) (15)
Ultrastructural study of the osteointegration of bioceramics (whitlockite and composite beta-TCP + collagen) in rabbit bone. (1996) (15)
Genotype–phenotype relationship for six common polymorphisms in genes affecting platelet function from 286 healthy subjects and 160 patients with mucocutaneous bleeding of unknown cause (2009) (15)
Down Regulation of the Munc18b-syntaxin-11 Complex and β1-tubulin Impairs Secretion and Spreading in Neonatal Platelets (2017) (15)
In vivo effects of hyperthermia on the functional and conformational characteristics of antithrombin (2007) (14)
Association of autoantibodies against platelet glycoproteins Ib/IX and IIb/IIIa, and platelet‐reactive anti‐HIV antibodies in thrombocytopenic narcotic addicts (1996) (14)
GPI-anchor and GPI-anchored protein expression in PMM2-CDG patients (2013) (14)
miR-146a rs2431697 identifies myeloproliferative neoplasm patients with higher secondary myelofibrosis progression risk (2020) (14)
Factor-V (Arg506 --> Gln) mutation in ischemic cerebrovascular disease. (1997) (14)
High incidence of FXI deficiency in a Spanish town caused by 11 different mutations and the first duplication of F11: Results from the Yecla study (2017) (14)
miR-146a deficiency in hematopoietic cells is not involved in the development of atherosclerosis (2018) (14)
Congenital disorder of glycosylation (PMM2‐CDG) in a patient with antithrombin deficiency and severe thrombophilia (2012) (14)
Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia (2019) (14)
Polymorphisms in xenobiotic metabolizing genes (EPHX1, NQO1 and PON1) in lymphoma susceptibility: a case control study (2013) (14)
Factor XIII Val34Leu polymorphism in primary intracerebral haemorrhage. (2000) (14)
The Infective Polymerization of Conformationally Unstable Antithrombin Mutants May Play a Role in the Clinical Severity of Antithrombin Deficiency (2012) (14)
An early increase of CD56bright natural killer subset as dominant effect and predictor of response to extracorporeal photopheresis for graft‐versus‐host disease (2018) (14)
Leukemic transformation driven by an ASXL1 mutation after a JAK2V617F-positive primary myelofibrosis: clonal evolution and hierarchy revealed by next-generation sequencing (2013) (13)
β-Trace protein and prognosis in patients with atrial fibrillation receiving anticoagulation treatment. (2013) (13)
Incidence and features of thrombosis in children with inherited antithrombin deficiency (2019) (13)
Genotype-guided therapy improves initial acenocoumarol dosing (2016) (13)
Repeated infusions of DDAVP induce low response of FVIII and vWF but not of plasminogen activators. (1993) (13)
Role of genetic polymorphisms in NFKB-mediated inflammatory pathways in response to primary chemoradiation therapy for rectal cancer. (2014) (13)
Evaluation of Leukocyte‐Depleted Platelet Concentrates Obtained by In‐Line Filtration (2000) (13)
Genetic predisposition to fetal alcohol syndrome: association with congenital disorders of N-glycosylation (2018) (13)
Molecular, ultrastructural and functional characterization of a Spanish family with Hermansky–Pudlak syndrome: role of insC974 in platelet function and clinical relevance (2003) (13)
Role of Factor Xiii Val 34 Leu Polymorphism in Patients with Migraine (2001) (13)
Qualitative and Quantitative Comparison of Plasma Exosomes from Neonates and Adults (2021) (12)
Proteomic analysis of platelet N-glycoproteins in PMM2-CDG patients. (2014) (12)
Differential miRNA expression profile and proteome in plasma exosomes from patients with paroxysmal nocturnal hemoglobinuria (2019) (12)
Role of GSTT1 and M1 null genotypes as risk factors for B‐cell lymphoma: Influence of geographical factors and occupational exposure (2012) (12)
CALU A29809G polymorphism in coronary atherothrombosis: Implications for coronary calcification and prognosis (2010) (12)
Safety evaluation and nutritional composition of a Fraxinus excelsior seed extract, FraxiPure™. (2013) (12)
Evaluation of a new whole‐blood filter that allows preparation of platelet concentrates by platelet‐rich plasma methods (2003) (12)
von Willebrand factor contained in a high purity FVIII concentrate (Fanhdi) binds to platelet glycoproteins and supports platelet adhesion to subendothelium under flow conditions. (1999) (12)
Quality assessment of buffy‐coat‐derived leucodepleted platelet concentrates in PAS‐plasma, prepared by the OrbiSac or TACSI automated system (2014) (12)
A pilot study on the impact of congenital thrombophilia in COVID‐19 (2021) (12)
Increasing therapy‐related myeloid neoplasms in multiple myeloma (2018) (12)
Neutrophil extracellular traps and von Willebrand factor are allies that negatively influence COVID‐19 outcomes (2021) (12)
Prognostic signature and clonality pattern of recurrently mutated genes in inactive chronic lymphocytic leukemia (2015) (12)
Control of post-translational modifications in antithrombin during murine post-natal development by miR-200a (2013) (12)
Activated protein C:α1-antitrypsin (APC:α1AT) complex as a marker for in vitro diagnosis of prethrombotic states (1992) (12)
Disease-causing mutations in the serpin antithrombin reveal a key domain critical for inhibiting protease activities (2017) (12)
Administration of post-autologous PBSCT rhG-CSF is associated with long-term low concentrations of bone marrow hematopoietic progenitor cells (2001) (12)
Inhibition of proteasome by bortezomib causes intracellular aggregation of hepatic serpins and increases the latent circulating form of antithrombin (2008) (11)
Elevated thrombin generation in patients with congenital disorder of glycosylation and combined coagulation factor deficiencies (2019) (11)
Intracellular retention of hepatic serpins caused by severe hyperlipidemia (2006) (11)
Effect of cold-storage in the accumulation of bioreactive substances in platelet concentrates treated with second messenger effects. (2001) (11)
Assessment of two contact activation reagents for the diagnosis of congenital factor XI deficiency. (2018) (11)
IgM monoclonal component associated with type I Gaucher disease resolved after enzyme replacement therapy: A case report (2009) (11)
Differences in phycoerythrin- or fluorescein-isothiocyanate conjugated 8G12 on CD34+ cell evaluation. (1997) (10)
Prognostic value of annexin A5 −1 C/T polymorphism in a long term follow‐up after premature myocardial infarction (2007) (10)
In vitro changes of platelet parameters: lessons from blood banking. (2004) (10)
MicroRNAs as potential regulators of platelet function and bleeding diatheses (2019) (10)
Underlying disorders of disseminated intravascular coagulation: Communication from the ISTH SSC Subcommittees on Disseminated Intravascular Coagulation and Perioperative and Critical Care Thrombosis and Hemostasis (2020) (10)
MPI-CDG with transient hypoglycosylation and antithrombin deficiency (2018) (10)
Identification of Antithrombin-Modulating Genes. Role of LARGE, a Gene Encoding a Bifunctional Glycosyltransferase, in the Secretion of Proteins? (2013) (10)
[Hypercoagulability and exanthematous Mediterranean fever]. (1991) (10)
Heparin affinity of factor VIIa: implications on the physiological inhibition by antithrombin and clearance of recombinant factor VIIa. (2011) (10)
The JAK2 46/1 haplotype does not predispose to CALR-mutated myeloproliferative neoplasms (2015) (10)
Influence of the F12-4 C>T polymorphism on hemostatic tests (2010) (10)
DDAVP in uremia. (1984) (10)
Influence of CYP2C19 polymorphisms in platelet reactivity and prognosis in an unselected population of non ST elevation acute coronary syndrome. (2012) (10)
Generation of induced pluripotent stem cells (iPSCs) from a Bernard-Soulier syndrome patient carrying a W71R mutation in the GPIX gene. (2016) (10)
Mobilization of hematopoietic progenitor cells with paclitaxel (taxol) as a single chemotheraupetic agent, associated with rhG-CSF (2000) (10)
Identification of novel variants in ten patients with Hermansky-Pudlak syndrome by high-throughput sequencing (2019) (10)
RASGRP2 gene variations associated with platelet dysfunction and bleeding (2019) (10)
Portal and mesenteric venous thrombosis in a patient heterozygous for the 20210 A allele of the prothrombin gene. (1998) (9)
Defects of splicing in antithrombin deficiency (2017) (9)
Successful mobilization of hematopoietic peripheral blood progenitor cells with paclitaxel-based chemotherapy as initial or salvage regimen in patients with hematologic malignancies (2008) (9)
A comparative study of two third-generation anti-hepatitis C virus ELISAs. (1997) (9)
Genetic determinants of platelet function in thromboembolic diseases. (2004) (9)
Influence of CYP2C19 Polymorphisms in Platelet Reactivity and Prognosis in an Unselected Population of Non ST Elevation Acute Coronary Syndrome (2012) (9)
Protein Z‐dependent protease inhibitor W303X mutation in venous thrombosis (2005) (9)
Evaluation of refrigerated platelet concentrates supplemented with low doses of second messenger effectors. (2004) (9)
Increased N-Glycosylation Efficiency by Generation of an Aromatic Sequon on N135 of Antithrombin (2014) (9)
Platelet GP Ib/IX/V complex: physiological role (2000) (9)
Effect of G-CSF on the Haemostatic System (1994) (9)
Mutation analysis of HPS1, the gene mutated in Hermansky-Pudlak syndrome, in patients with isolated platelet dense-granule deficiency. (2004) (9)
ALG12‐CDG: An unusual patient without intellectual disability and facial dysmorphism, and with a novel variant (2020) (9)
[Prognostic value of tumor necrosis factor-alpha in patients with ST-segment elevation acute myocardial infarction]. (2007) (9)
[Spanish consensus statement for diagnosis and treatment of paroxysmal nocturnal haemoglobinuria]. (2016) (9)
Prognostic value of computed tomography pulmonary angiography indices in patients with cancer-related pulmonary embolism: Data from a multicenter cohort study. (2017) (8)
Oral contraceptives highlight the genotype-specific association between serum phospholipids and activated factor VII. (1999) (8)
JAK2 V617F, hemostatic polymorphisms, and clinical features as risk factors for arterial thrombotic events in essential thrombocythemia (2008) (8)
First exploratory study on the metabolome from plasma exosomes in patients with paroxysmal nocturnal hemoglobinuria. (2019) (8)
Thermochemotherapy for B16 melanoma: combination therapy of hyperthermia, melphalan, and CCNU in mice. (1990) (8)
Factor XII in PMM2-CDG patients: role of N-glycosylation in the secretion and function of the first element of the contact pathway (2020) (8)
Uniparental disomy causes deficiencies of vitamin K‐dependent proteins (2016) (8)
Prediction of long‐term net clinical outcomes using the TIMI‐AF score: Comparison with CHA2DS2‐VASc and HAS‐BLED (2018) (8)
Hyperglycaemia impairs antithrombin secretion: possible contribution to the thrombotic risk of diabetes. (2009) (8)
Human platelet antigen systems in allogeneic peripheral blood progenitor cell transplantation: effect of human platelet antigen mismatch on platelet engraftment and graft‐versus‐host disease (2004) (8)
In Vitro Changes of Platelet Parameters (2004) (8)
Developmental Differences in Platelet Inhibition Response to Prostaglandin E1 (2019) (7)
Protein C and antithrombin III in acute myocardial infarction. (1986) (7)
A new method to quantify β-antithrombin glycoform in plasma reveals increased levels during the acute stroke event. (2015) (7)
N-Glycosylation as a Tool to Study Antithrombin Secretion, Conformation, and Function (2021) (7)
Effect of VKORC1, CYP2C9 and CYP4F2 genetic variants in early outcomes during acenocoumarol treatment. (2014) (7)
Role of the C‐sheet in the maturation of N‐glycans on antithrombin: functional relevance of pleiotropic mutations (2014) (7)
Bone marrow steady-state CD34+/CD71− cell content is a predictive value of rG-CSF-mobilized CD34+ cells (1998) (7)
Pilot Study on the Role of Circulating miRNAs for the Improvement of the Predictive Ability of the 2MACE Score in Patients with Atrial Fibrillation (2020) (7)
MicroRNAs as New Regulators of Neutrophil Extracellular Trap Formation (2021) (7)
Leukaemic Transformation in Patients with Haematological Disease Receiving Tumour Necrosis Factor Inhibitors (2012) (7)
Effects of acrolein, a natural occurring aldehyde, on the anticoagulant serpin antithrombin (2009) (7)
Identification of a New Mechanism of Antithrombin Deficiency Hardly Detected by Current Methods: Duplication of SERPINC1 Exon 6 (2018) (6)
In vitro analysis of platelet concentrates stored in the presence of modulators of 3',5' adenosine monophosphate, and organic anions. (2000) (6)
[Economic evaluation of rituximab added to fludarabine plus cyclophosphamide versus fludarabine plus cyclophosphamide for the treatment of chronic lymphocytic leukemia]. (2011) (6)
Aplastic Anaemia Induced by Ticlopidine after Placement of Coronary Artery Stents (1998) (6)
[Effect of the early administration of pravastatin on C-reactive protein and interleukin-6 levels in the acute phase of myocardial infarction with ST segment elevation]. (2004) (6)
Complex formation between protein c inhibitor and tissue plasminogen activator during thrombolytic therapy: Evidence of activation of protein C pathway (1993) (6)
Erythrophagocytosis in de novo-philadelphia-positive acute leukemia of ambiguous lineage. (2006) (6)
Absence of Effect of DDAVP Infusion on Platelet Glycoprotein Ib/IX and IIb/IIIa Complexes, and their Interaction with Newly Released von Willebrand Factor. (1993) (6)
Allogeneic hematopoietic cell transplantation in an adult patient with Glanzmann thrombasthenia (2017) (6)
Identification of a new potential mechanism responsible for severe bleeding in myeloma: immunoglobulins bind the heparin binding domain of antithrombin activating this endogenous anticoagulant (2016) (6)
Particulate Matter and Temperature: Increased Risk of Adverse Clinical Outcomes in Patients With Atrial Fibrillation. (2020) (6)
Platelet activation and neutrophil extracellular trap (NET) formation in immune thrombocytopenia: is there an association? (2019) (6)
Identification of the first large intronic deletion responsible of type I antithrombin deficiency not detected by routine molecular diagnostic methods (2019) (6)
An atypical IgM class platelet cold agglutinin induces GPVI-dependent aggregation of human platelets (2015) (6)
Kinin-prekallikrein system in Mediterranean spotted fever. (1986) (6)
Evaluation of Leukocyte–Depleted Platelet Concentrates Obtained by In–Line Filtration (2000) (6)
A decade of changes in management of immune thrombocytopenia, with special focus on elderly patients. (2020) (5)
Genotype–phenotype gradient of SERPINC1 variants in a single family reveals a severe compound antithrombin deficiency in a dead embryo (2020) (5)
[Platelet concentrates from whole-blood donations (buffy-coat) or apheresis: which one to use?]. (2012) (5)
PTGS1 gene variations associated with bleeding and platelet dysfunction (2020) (5)
Transcriptomic rationale for synthetic lethality‐targeting ERCC1 and CDKN1A in chronic myelomonocytic leukaemia (2018) (5)
Dexamethasone induction of a heat stress response. (2011) (5)
Two SERPINC1 variants affecting N-glycosylation of Asn224 cause severe thrombophilia not detected by functional assays (2022) (5)
Molecular and clinical characterization of transient antithrombin deficiency: A new concept in congenital thrombophilia (2021) (5)
Minimal Residual Disease in Multiple Myeloma: Something Old, Something New (2021) (5)
Congenital antithrombin deficiency in patients with splanchnic vein thrombosis (2019) (5)
TUBB1 Q43P polymorphism does not protect against acute coronary syndrome and premature myocardial infarction (2008) (5)
Genetic variants of the extra‐large stimulatory Gs protein alpha‐subunit and risk of thrombotic and haemorrhagic disorders (2004) (5)
Potential and current development of platelet products. (1999) (5)
Current opinion and consensus statement regarding the diagnosis, prognosis, and treatment of patients with essential thrombocythemia: a survey of the Spanish Group of Ph-negative Myeloproliferative Neoplasms (GEMFIN) using the Delphi method (2016) (5)
Effects of oral anticoagulant therapy and haplotype 1 of the endothelial protein C receptor gene on activated protein C levels (2012) (5)
Antithrombin p.Thr147Ala: The First Founder Mutation in People of African Origin Responsible for Inherited Antithrombin Deficiency (2020) (5)
ABEL trial: A phase II randomized trial adding bemiparin (B) to chemo-radiotherapy (CT-RT) in limited-stage small cell lung cancer (SCLC)—Final results. (2012) (5)
Inherited thrombophilic conditions (2012) (5)
Long-read sequencing resolves structural variants in SERPINC1 causing antithrombin deficiency and identifies a complex rearrangement and a retrotransposon insertion not characterized by routine diagnostic methods (2020) (5)
Spanish consensus statement for diagnosis and treatment of paroxysmal nocturnal haemoglobinuria (2016) (5)
miR-146a in Cardiovascular Diseases and Sepsis: An Additional Burden in the Inflammatory Balance? (2020) (5)
High levels of circulating von Willebrand factor inhibit the release of this protein but not of plasminogen activator after DDAVP. (1985) (5)
Acute phase reactants and clinical stages in multiple myeloma. (1981) (5)
Guidelines of the Spanish ITP Group for the diagnosis, treatment and follow-up of patients with immune thrombopenia. (2021) (4)
High penetrance of inferior vena cava system atresia in severe thrombophilia caused by homozygous antithrombin Budapest 3 variant: Description of a new syndrome (2021) (4)
Fibrinolytic changes during acute vascular damage induced by Mediterranean spotted fever (1993) (4)
The FXII c.-4T>C Polymorphism as a Disease Modifier in Patients With Hereditary Angioedema Due to the FXII p.Thr328Lys Variant (2020) (4)
An increased percentage of myeloid CD34+ bone marrow cells stratifies intermediate IPSS‐R myelodysplastic syndrome patients into prognostically significant groups (2018) (4)
Frozen and cold-stored platelets: reconsidered platelet products (2021) (4)
Pharmacogenetics of vitamin K antagonists and bleeding risk prediction in atrial fibrillation (2018) (4)
Efficacy and safety of peri-procedural bridging therapy with low molecular weight heparin in atrial fibrillation patients under vitamin K antagonists (2018) (4)
The irreplaceable image: IgA multiple myeloma with multiple cutaneous plasmacytomas. (2001) (4)
Antiplatelet therapy combined with acenocoumarol in relation to major bleeding, ischaemic stroke and mortality (2018) (4)
Effect of factor VII −323 Del/Ins polymorphism on the daily variability of factor VIIc and INR in steady anticoagulated patients with acenocoumarol (2004) (4)
Platelet aggregation through prothrombinase activation induced by non-aggregant doses of platelet agonists (2002) (4)
Heparanase Activates Antithrombin through the Binding to Its Heparin Binding Site (2016) (4)
Studies on platelet surface carbohydrates in normal and uraemic platelets using 125I-labelled lectins (1985) (4)
Factor VIII-Related Antigen in Cerebrospinal Fluid (1983) (4)
Cancer testis antigens in myelodysplastic syndromes revisited: a targeted RNA-seq approach (2020) (4)
Transient desialylation in combination with a novel antithrombin deficiency causing a severe and recurrent thrombosis despite anticoagulation therapy (2017) (4)
Expanding the genetic spectrum of TUBB1-related thrombocytopenia (2021) (4)
EFFECT OF DDAVP ON CONTACT PHASE OF BLOOD COAGULATION (1984) (4)
Fatal upper and lower gastrointestinal cytomegalovirus disease following autologous peripheral blood stem cell transplantation (2001) (4)
Cerebrospinal fluid levels beta 2 microglobulin and ferritin in lymphoproliferative disorders. (1982) (4)
Quality assessment and transfusion efficacy of buffy coat-derived platelet concentrates washed with platelet additive solution. (2018) (4)
Coexistence of three genetic risk factors in a Spanish thrombophilic family: Factor V Leiden, prothrombin 20210 and a new type I antithrombin deficiency (2006) (4)
Bone-marrow immunophenotypic analysis allows the identification of high risk of progression and immune condition-related monoclonal gammopathy of undetermined significance (2009) (4)
Gamma-glutamyl carboxylase R325Q polymorphism on the response of acenocoumarol. (2008) (4)
Preleukapheresis peripheral blood CD34+ cells predict progenitor cell collection yield and the necessary number of procedures to undergo. (1999) (3)
Antithrombin deficiency as a still underdiagnosed thrombophilia: a primer for internists. (2020) (3)
Antithrombin is incorporated into exosomes produced by antithrombin non-expressing cells. (2019) (3)
T cells subpopulations in untreated and treated patients with haemophilia A and B (1983) (3)
High sensitivity cardiac troponin T and interleukin‐6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation: a reply to a rebuttal (2012) (3)
Long-Read Sequencing Identifies the First Retrotransposon Insertion and Resolves Structural Variants Causing Antithrombin Deficiency (2022) (3)
EVIDENCE OF DEGRADATION OF FACTOR VIII‐ANTIGEN IN ASCITIC FLUID (1983) (3)
Effect of hepatitis C virus infection on the lymphoid population in hemophiliacs. (1991) (3)
Synergism between factor XII –4C>T and factor XIII Val34Leu polymorphisms in fibrinolytic therapy in acute myocardial infarction (2010) (3)
Study of 18 functional hemostatic polymorphisms in mucocutaneous bleeding disorders (2010) (3)
Identification of Circulating microRNA Signatures As Potential Noninvasive Biomarkers for Prediction to Response to Extracorporeal Photoapheresis in Patients with Graft Versus Host Disease (2019) (3)
Activated protein C: alpha 1-antitrypsin (APC: alpha 1 AT) complex as a marker for in vitro diagnosis of prethrombotic states. (1992) (3)
Evaluation of two‐step haemoglobin screening with HemoCue for blood donor qualification in mobile collection sites (2014) (3)
Molecular dissection of structural variations involved in antithrombin deficiency. (2022) (3)
Compound heterozygosity involving Antithrombin Cambridge II (p.Ala416Ser) in antithrombin deficiency (2013) (3)
The prognostic impact of additional intrathoracic findings in patients with cancer-related pulmonary embolism (2018) (3)
Fibrin monomers improves stroke risk stratification in chronic anticoagulated non-valvular atrial fibrillation patients (2013) (3)
Gynaecological and obstetrical bleeding in Caucasian women with congenital factor XI deficiency: Results from a twenty-year, retrospective, observational study. (2019) (3)
Fatal upper and lower gastrointestinal cytomegalovirus disease following autologous peripheral blood stem cell transplantation. (2001) (3)
[Pulmonary embolism in patients with cancer: foundations of the EPIPHANY study]. (2015) (3)
Incidence of deep venous thrombosis associated with central venous catheters (DVT-CVC) in cancer patients: A multicenter study. (2006) (3)
Effect of rhG-CSF on the mobilization of CD38 and HLA-DR subfractions of CD34+ peripheral blood progenitor cells (1995) (3)
Economic evaluation of rituximab added to fludarabine plus cyclophosphamide versus fludarabine plus cyclophosphamide for the treatment of chronic lymphocytic leukemia (2011) (3)
Murcia atrial fibrillation project II: protocol for a prospective observational study in patients with atrial fibrillation (2019) (3)
[Retrospective analysis of the efficacy and tolerability of anagrelide in patients with essential thrombocytemia: Spanish registry of essential thrombocytemia]. (2009) (3)
Comparative study of three methods to detect free plasma antiplatelet antibodies. (1996) (3)
Anti-Tumor Functions of Prelatent Antithrombin on Glioblastoma Multiforme Cells (2021) (3)
Changes of contact phase proteins during haemodialysis. (1988) (2)
[New oral anticoagulants: a multidisciplinary approach]. (2009) (2)
Ulcer necrotic legs as first manifestation of protein S deficiency (1987) (2)
INHIBITOR OF PROTEIN C AND COMBINED DEFICIENCY OF FACTORS V AND VIII (1983) (2)
Nonsense mutation in the glycoprotein Iba coding sequence associated with Bernard-Soulier syndrome (platelet receptor/thrombosis/bleeding disorder/platelet adhesion/thrombocytopenia) (2016) (2)
Predictive Factors for Thrombopoietin Receptor Agonist Free Responses in Chronic ITP Patients: A Multicenter Retrospective Study with Long-Term Follow-up (2019) (2)
Design and Validate of Next-Generation Sequencing Panel for Inherited Platelet Disorders (2014) (2)
New congenital deficiency of high molecular weight kininogen and prekallikrein (Fitzgerald trait). Study of response to DDAVP and venous occlusion. (1986) (2)
Generation of a human induced pluripotent stem cell (iPSC) line from a Bernard-Soulier syndrome patient with the mutation p.Asn45Ser in the GPIX gene. (2016) (2)
Effect of hepatitis C virus infection on the lymphoid population in hemophiliacs [letter; comment] (1991) (2)
[Economic costs of autotransplantation of hematopoietic progenitors]. (1996) (2)
[Autologous transplant with BEAM protocol in lymphoma]. (1997) (2)
Does Subunit A of Factor XIII Regulate the Plasma Concentration of Subunit B? (1983) (2)
A novel genetic variant in PTGS1 affects N‐glycosylation of cyclooxygenase‐1 causing a dominant‐negative effect on platelet function and bleeding diathesis (2020) (2)
Biochemical and cellular consequences of the antithrombin p.Met1? mutation identified in a severe thrombophilic family (2018) (2)
EFFECT OF DDAVP ON MYOCARDIAL INFARCT SIZE (1987) (2)
Acute phase reactant proteins in differential diagnosis of monoclonal gammopathy. (1983) (2)
A Modern Approach to the Molecular Diagnosis of Inherited Bleeding Disorders (2018) (2)
C0380: Clinical and Biochemical Consequences of Met1Ileu Mutation in Serpinc1 Gene: Generation of a Small Non-Inhibitory Antithrombin Variant without the N-Terminal Region by Use of an Alternative Initiation Codon that Has a Strong Gain-Of-Function Associated WI (2014) (2)
Tumor-infiltrating immune cell profiles and their change after neoadjuvant chemotherapy predict response and prognosis of breast cancer (2014) (2)
Measuring the prognostic impact of ferritin levels in myelodysplastic syndrome patients: the role of susceptibility biases (2010) (2)
Evaluation of Novel Platelet Polymorphisms in Stroke. Dichotomic Effect of rs5443 in GNB3 (2015) (2)
[Clinical perspectives on the management of bleeding in patients on oral anticoagulants: the DECOVER Study (DElphi Consensus on oral COagulation and therapy action reVERsal)]. (2017) (2)
Identification of Thrombosis-Related Genes in Patients with Advanced Gastric Cancer: Data from AGAMENON-SEOM Registry (2022) (2)
Implication of Hepsin from Primary Tumor in the Prognosis of Colorectal Cancer Patients (2022) (2)
Archeogenetics of F11 p.Cys38Arg: a 5400-year-old mutation identified in different southwestern European countries. (2019) (2)
Do Guidelines Influence Diagnostic and Therapeutic Practice in Immune Thrombocytopenia? Results of a Multicenter Retrospective Study (2019) (1)
Hydroxyurea Reduces Neutrophil Extracellular Trap Formation in Myeloproliferative Neoplasms (2020) (1)
A radioreceptor assay for mass measurement of inositol (1,4,5)-trisphosphate using saponin-permeabilized outdated human platelets. (1998) (1)
[Subcutaneous administration of desmopressin to plasma donors: a controlled study]. (1995) (1)
Intranasal desmopressin in mild hemophilia. (1985) (1)
[Hypogammaglobulinemia and multiple myeloma]. (1981) (1)
[The use of desmopressin in the treatment of hemorrhagic syndromes]. (1990) (1)
Factor VIII half-life and intensity of treatment in hemophilic patients. (2005) (1)
[Markers of hemostatic activation in the coronary sinus versus peripheral circulation in coronary artery disease. Effects of percutaneous transluminal coronary angioplasty]. (1998) (1)
Von Willebrand's Syndrome Associated with von Recklinghausen Neurofibromatosis (1982) (1)
[Purification and immunocharacterization of platelet membrane glycoproteins using affinity chromatography with selected lectins]. (1983) (1)
Detection of free hepatitis C virus core antigen by enzyme‐linked immunosorbent assay is not suitable for screening of granulocyte colony‐stimulating factor‐mobilized hematopoietic progenitor donors (2004) (1)
Induced pluripotent stem cells derived from Bernard-Soulier Syndrome patient's peripheral blood cells with a p.Phe55Ser mutation in the GPIX gene. (2017) (1)
C0271: Incidental Versus Symptomatic Pulmonary Embolism (PE) in Cancer Patients: Clinical Features and Short Term Outcomes of 562 Consecutive Patients from the Epiphany Study (2014) (1)
Re-mobilization of peripheral blood progenitor cells within a short time interval fails to achieve effective progenitor cell yields (2000) (1)
Antithrombotic therapy after coronary-artery stenting. (1999) (1)
[Diagnosis and treatment of nocturnal paroxysmal hemoglobinuria]. (2011) (1)
Glycoprotein IIb/IIIa expression on hematopoietic stem cells: constitutive expression or platelet adhesion? (1999) (1)
[DDAVP: biological effect and clinical utility]. (1994) (1)
Thrombin in the Activation of the Fluid Contact Phase in Patients with Hereditary Angioedema Carrying the F12 P.Thr309Lys Variant (2021) (1)
[Aprotinin: its biological effect and clinical usefulness]. (1995) (1)
Mode of inheritance of type II protein S deficiency. (1986) (1)
Letter to the editor: Hemostasis in malignancy (1991) (1)
Thermotherapy for Harding-Passey melanoma: light and electron microscopic study. (1987) (1)
Full-length antithrombin frameshift variant with aberrant C-terminus causes endoplasmic reticulum retention with a dominant-negative effect (2022) (1)
Correction: Identification of Regulatory Mutations in SERPINC1 Affecting Vitamin D Response Elements Associated with Antithrombin Deficiency (2016) (1)
Heparin versus aspirin thromboprophylaxis adds independent value to IMPEDE-VTE score for venous thrombosis prediction in multiple myeloma (2021) (1)
ABO blood group does not increase the risk of thrombosis in Philadelphia-negative myeloproliferative disorders. (2009) (1)
Control of post-translational modifications in antithrombin during murine post-natal development by miR-200a (2013) (1)
A cytologic study of the sediments in pericardial fluid as it relates to a diagnosis of the mechanism of death (2004) (1)
Two new cases of congenital dysfibrinogenemia with impaired aggregation of monomers: Fibrinogens Salamanca II and Santander I (1986) (1)
PROTEIN C AND FACTOR VIII LABILITY (1985) (1)
[Primary antiphospholipid syndrome in juvenile ischemic stroke]. (1993) (1)
Hemostasis in malignancy. (1991) (1)
increases the risk for venous thrombosis A nonsense polymorphism in the protein Z-dependent protease inhibitor (2014) (1)
[Current treatment of primary immune thrombocytopenia]. (2014) (1)
[Economic cost of peripheral blood progenitor cell transplantation in Spain]. (2004) (1)
Abstract P5-01-08: Changes induced by neoadjuvant chemotherapy (NCT) in breast cancer tumor infiltrating lymphocytes (TIL) subpopulations are associated with chemo-sensitivity and prognosis (2013) (1)
Mode of inheritance of type II protein S deficiency [letter] (1986) (1)
Coagulation proteins showing abnormal electrophoretic mobility in commercial concentrates of factor VIII and prothrombin complex. (1984) (1)
CXCR4 allelic Variations Influence Hematological Recovery Following Autologous Stem Cell Transplantation (2011) (1)
associated with a prolonged bleeding time Controlled trial of desmopressin in liver cirrhosis and other conditions (2011) (1)
Anticipating High-Risk Chromosome Clonal Evolution in Chronic Lymphocytic Leukemia: A Next Generation Sequencing and Longitudinal FISH Combined Study (2014) (1)
[Immunoglobulin subclasses and multiple myeloma. Clinico-biological correlations, with special reference to IgG3 myelomas (author's transl)]. (1980) (1)
Lupus anticoagulant and false positive serological tests for syphilis. (1987) (1)
C0418: miRNAs 16, 424 and 29C Regulate VEGF-A Expression in Endometrial Stromal Cells from Women with Endometriosis (2014) (1)
Src-related thrombocytopenia: a fine line between a megakaryocyte dysfunction and an immune-mediated disease (2022) (1)
Transient massive peripheral blood blastosis in patient with renal clear-cell carcinoma after treatment with high-dose recombinant interleuklin-2. (2007) (1)
[Platelet transfusion; concentrates from single or from multiple donors?]. (2004) (0)
Influence of Genetic Polymorphisms in CYP2C8 and ABCB1 on the Mobilization Ability and Toxicity of Paclitaxel (2011) (0)
Severe biochemical and functional effects in antithrombin caused by acrolein (2009) (0)
PO-0691: Impact of genetic polymorphisms related inflammatory response mediated NFkB in resistance to nRCT in rectal cancer (2013) (0)
[Structural and immunochemical study of platelet membrane glycoproteins]. (1983) (0)
Platelet Antiaggregant Therapy Prevents Venous Thrombosis in Patients with JAK2 V617F Positive Essential Thrombocythemia without Indication of Cytoreductive Treatment. (2009) (0)
C0094 High incidence of compound heterozygosity in antithrombin deficiency: Diagnostic and prognostic relevance (2012) (0)
Clinical and biological impact of miR-18a expression in breast cancer after neoadjuvant chemotherapy (2019) (0)
Implications for Conformational Diseases (2006) (0)
C0075 Type II antithrombin deficiency caused by a large in-frame insertion. Structural, functional and pathological relevance (2012) (0)
BILLIARY CIRRHOSIS: CONFORMATIONAL EFFECTS AND CONSEQUENCES OF THE OXIDATION OF HEPATIC SERPINS (2007) (0)
DDAVP and Tachyphylaxis in Healthy Subjects (1993) (0)
[Primary thrombophilia and pregnancy]. (1993) (0)
[Hemophilia. A disappearing disease?]. (1991) (0)
Abstract P5-15-09: Evaluation of growth modulation index as a marker of benefit for consecutive lines of treatment for metastatic breast cancer (2017) (0)
[Molecular complex of factor VIII (antihemophilic factor) in hepatopathies]. (1979) (0)
PF690 PREDICTORS OF THERAPY FREE RESPONSES IN ITP PATIENTS RECEIVING TPO-RA. RESULTS FROM A SPANISH MULTICENTER STUDY (2019) (0)
Use of low molecular weight heparins in thromboembolic disease. (2000) (0)
Thrombotic coagulopathy and COVID-19 (2020) (0)
Abstract PD2-4: Association between body mass index change during neoadjuvant chemotherapy and pathologic complete response and overall survival in patients with inflammatory breast cancer or locally advanced non-inflammatory breast cancer (2013) (0)
[Comparative multicenter study of a rabbit high-sensitivity thromboplastin and a recombinant thromboplastin with synthetic phospholipids]. (1994) (0)
P5831Evaluation of ABC-stroke and CHA2DS2-VASc ischemic scores in real-world atrial fibrillation patients receiving oral anticoagulation treatment (2017) (0)
PF339 BIOLOGICAL AND CLINICAL FACTORS THAT FAVOR THE USE OF A SPECIFIC TPO-RA IN ITP PATIENTS. RESULTS FROM A SPANISH MULTICENTER STUDY (2019) (0)
Author Correction: Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia (2021) (0)
[Hemoblastosis and factor VIII complex (antihemophilic factor)]. (1979) (0)
[Plasminogen deficiencies in 2 Spanish families. Response to the administration of DDAVP]. (1990) (0)
Massive intestinal infiltration in a patient with bone T-cell rich diffuse large B cell lymphoma. (2003) (0)
Prognostic value of decrease on blood lymphocytes in breast cancer patients undergoing primary chemotherapy. (2016) (0)
Clinical Characteristics and Cardioavscular Events in Patients with Esential Thrombocythemia with <10% Vs. ≥10% JAK2 V617F Allele Burden (2019) (0)
Validation of SAME-TT2R2 score for predicting poor anticoagulation in a prospective real world cohort of atrial fibrillation patients initiating Vitamin K antagonists (2015) (0)
[Present-day conception of von Willebrand's disease (author's transl)]. (1978) (0)
ROLE OF TISSUE REMODELLING IN HYPERTROPHIC MYOCARDIOPATHY (2007) (0)
Outpatient management of cancer-related pulmonary embolism: Analysis of 562 consecutive patients from the EPIPHANY study. (2014) (0)
Evaluation of the prognostic value and phenotypic determinants of Bcl-2 expression in breast invasive carcinoma. (2012) (0)
C0403: Gene Expression Differences Between Neonatal and Adult Platelets: New Potential Modulators of Human Platelet Reactivity (2014) (0)
Circulating endothelial microparticles (EMP) modifications as predictive biomarkers of resistance to chemotherapy for breast cancer (BC). (2013) (0)
' s response to reviews Title : Polymorphisms in xenobiotic metabolizing genes ( EPHX 1 , NQO 1 and PON 1 ) in lymphoma susceptibility : a case control study (0)
Systemic or Venous Thromboembolism Antithrombin Dublin ( p . Val 30 Glu ) : a relatively common variant with moderate thrombosis risk of causing transient antithrombin deficiency (0)
C0378: The Predictive Value of the SAME-TT2R2 Score for Anticoagulation Control and Adverse Outcomes in Anticoagulated Patients with Atrial Fibrillation (2014) (0)
NAD(P)H oxidase genetic polymorphisms and anthracyclines-induced cardiac lesions in patients with cancer. (2011) (0)
Metastatic breast cancer (MBC) patients′ perspective in the valuation of health states for QALY calculation. (2016) (0)
Activation of kinin-prekallikrein system after infusion of factor VIII concentrates in hemophilic patients. (1986) (0)
[DDAVP: alternative therapy in moderate pathology of Factor VIII/von Willebrand]. (1983) (0)
Pro-tumor and prothrombotic activities of hepsin in colorectal cancer cells and suppression by venetoclax (2022) (0)
Differential miRNA expression profile and proteome in plasma exosomes from patients with paroxysmal nocturnal hemoglobinuria (2019) (0)
Impact of Constitutional Polymorphisms in VCAM1, CD44, CXCL12, CXCR4 and CSF3R in Progenitor Cell Mobilization in Patients with Hematological Malignancies (2011) (0)
Strategies for Analysis of Novel Molecular Variants in the RUNX1 Gene As a Cause of Familial Platelet Disorder with Predisposition to Acute Myeloid Leukemia (FPD/AML) (2019) (0)
915PPROGNOSTIC VALUE OF MULTIDISCIPLINAR GYNAECOLOGICAL COMMITTE IN OVARIAN CANCER PATIENTS. (2014) (0)
[Acquired immunodeficiency syndrome and the treatment of hemophilia]. (1983) (0)
Usefulness of the 2 MACE score to predicts adverse cardiovascular events in patients with atrial fibrillation (2017) (0)
Chronic Kidney Disease: Physiology argues against targeting high haemoglobin levels (2017) (0)
Supplementary material : Usefulness of the 2MACE Score to Predicts Adverse Cardiovascular Events in Patients With Atrial Fibrillation (2017) (0)
C0163: Immunoglobulin from Multiple Myeloma Interferes the Thrombin-Antithrombin Axis Causing a Severe Coagulopathy by Activation of Antithrombin (2014) (0)
rs2431697, a Polymorphism of Mir-146a, Is a Precozing Marker of Progression to Secondary Myelofibrosis: New Epigenetic Regulation of Jak/Stat3 Signaling (2018) (0)
Ten New Cases of Hermansky-Pudlak Syndrome in the Iberian Peninsula: Identification of Novel Genetic Variants in HPS3, HPS4, HPS6 and DTNBP1 Associated with Significant Clinical Complications (2018) (0)
Renal adiponectin as a biomarker of kidney disease in stable anticoagulated atrial fibrillation patients (2013) (0)
Bone Marrow Immunophenotypic Analysis Allows the Identification of High Risk of Progression and Immune Condition-Related Monoclonal Gammopathy of Undetermined Significance. (2009) (0)
C0547: Tissue Factor Pathway Inhibitor Expression is Regulated by miR-27a-3p in Endothelial Cells (2014) (0)
Role of anticholinesterase drugs in platelet aggregation. Relationship with Alzheimers disease (2000) (0)
MILD COVID-19 INFECTION PRESENTS FEW WEEKS LATER WITH DEVASTATING CARDIOVASCULAR INVOLVEMENT SEVERE LEFT VENTRICULAR IMPAIRMENT NONISCHEMIC CARDIOMYOPATHY (2022) (0)
Effects of several ̄avonoids on the growth of B16F10 and SK-MEL-1 melanoma cell lines: relationship between structure and activity (2002) (0)
[Other congenital hypercoagulable states]. (1997) (0)
A New Molecular Variant in the PTGS1 Gene That Abrogates Generation of Thromboxane A2 Synthesis and Associates with Platelet Dysfunction and Bleeding (2019) (0)
Effect of haemodialysis on the prekallikrein system (1986) (0)
C0260: Identification of RXRA/VDR Elements Involved in the Regulation of Antithrombin Levels. Relevance in Antithrombin Deficiency (2014) (0)
Polymorphisms in xenobiotic metabolizing genes (EPHX1, NQO1 and PON1) in lymphoma susceptibility: a case control study (2013) (0)
Subject Index Vol. 78, 2000 (2000) (0)
[Lymphocyte populations in hemophilia A and B. Relation to acquired immunodeficiency syndrome and therapeutic implications]. (1983) (0)
P1681: FXI LEVELS AS INDEPENDENT RISK FACTOR FOR THROMBOSIS/OBSTETRIC EVENTS IN PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES (2022) (0)
Response Predictive Factors to Anagrelide in Essential Thrombocythemia Diagnosed Patients. (2007) (0)
[Use of desmopressin in the treatment of mild forms of hemophilia A and von Willebrand's disease]. (1987) (0)
[Antibodies against hepatitis C virus in hemophiliacs: correlation with peripheral blood lymphocyte populations]. (1991) (0)
Detection of anomalies in cell-surface carbohydrates on thrombasthenic platelets using 125I-labeled lectins (1986) (0)
Contents, Vol. 14, 1984 (1984) (0)
[Familial thrombosis caused by protein S deficiency]. (1987) (0)
HEREDITARY THROMBOPHILIA CAUSED BY MISSENSE MUTATION IN PROTEIN C GENE (1987) (0)
[Interrelationship between complement and coagulation in human disseminated intravascular coagulation. II. The role of factor VII.) (author's transl)]. (1979) (0)
Subject Index, Vol. 46, 1987 (1987) (0)
[Interrelationship between complement and coagulation in human disseminated intravascular coagulation. I. The role of complement (author's transl)]. (1979) (0)
[Plasma concentrates of factor VIII. Where are we?]. (1989) (0)
MIR146A polymorphisms predict cardiovascular risk in atrial fibrillation patients (2013) (0)
Impact of genetic structural variants in FXI deficiency: identification, accurate characterization and inferred mechanism by long-read sequencing. (2023) (0)
C0229: Mutations Creating New Glycosylation Sites Cause Different Types of Antithrombin Deficiency. Role of an N-Glycan at the Reactive Centre Loop (2014) (0)
Correction: Increased N-Glycosylation Efficiency by Generation of an Aromatic Sequon on N135 of Antithrombin (2015) (0)
[Inhibitors of hemostasis in diabetes mellitus]. (1986) (0)
Enhancing the Genetic Diversity of FXI Deficiency: Structural Variants and New Cross Reactive Positive Variants (2022) (0)
Subject Index, Vol. 14, 1984 (1984) (0)
[Characterization of FVIII/VW circulating after DDAVP administration (author's transl)]. (1981) (0)
[Molecular pathology and clinicobiological correlations of IgD myeloma (author's transl)]. (1982) (0)
Influence of Age on Treatment with Thrombopoietin Receptor Agonists in Patients with Immune Thrombocytopenia; A Retrospective Multicenter Study (2019) (0)
Contents, Vol. 46, 1987 (1986) (0)
[Lymphocyte subpopulations and the presence of abnormal proteins in plasma concentrates]. (1985) (0)
Demostration of hipercoagulability in patients with mediterranean spotted fever (1986) (0)
DDAVP IN DIABETES INSIPIDUS (1987) (0)
SUBCUTANEOUS AND INTRAVENOUS ADMINISTRATION OF DESMOPRESSIN (DDAVP) TO HEMOPHILIACS: PLASMA PHARMACOKINETICS AND FACTOR VIII (VIII:C) RESPONSES (1987) (0)
Pharmacogenetics in the thrombolytic treatment of myocardial infarction: role of the FXIII V34L polymorphism (2003) (0)
Long-Read Sequencing Identi ﬁ es the First Retrotransposon Insertion and Resolves Structural Variants Causing Antithrombin De ﬁ ciency (2022) (0)
Identification By Longread Nanopore Sequencing of a Complex Structural Variant in ITGB3 with a Founder Effect Causing Glanzmann's Thrombasthenia in Two Unrelated Patients (2022) (0)
Prediction of long-term net clinical outcomes using the TIMI-AF score : Comparison with CHA 2 DS 2-VASc and HAS-BLED Cover title : Prediction of net clinical outcomes by the TIMI-AF (2017) (0)
Predictive value for thrombosis of pre-chemotherapy D-Dimer in ambulatory cancer patients. (2016) (0)
When genetic and surname analyses meet historical sources: The C56R mutation associated with factor XI deficiency as a marker of human migration during the Spanish Reconquista. (2020) (0)
C0504: A Randomized Trial of Genotype-Guided Dosing of Acenocoumarol in Spanish Population (2014) (0)
Beta-trace protein and prognosis in anticoagulated patients with atrial fibrillation (2013) (0)
Notch1 mutation in B Chronic Lymphocytic Lymphocytes Induces Proliferation through Cell Cycle G1/S Phase-Specific Cyclin Overexpression (2019) (0)
hemorrhage Polymorphisms of clotting factors modify the risk for primary intracranial (2013) (0)
5-21-11 ARG506GLN mutation (factor v leiden) in patients with coexisting stroke and migraine (1997) (0)
Platelet transcriptome analysis in patients with germline RUNX1 mutations. (2023) (0)
[The follow-up of the mobilization of circulating hematopoietic progenitor cells by granulocyte growth factor (G-CSF) using flow cytometry]. (1995) (0)
Disseminated aspergillosis after mobilization with intensive chemotherapy prior to autologous stem‐cell transplant in chronic myeloid leukemia (1997) (0)
Evaluation of the plasma kinin system in mediterranean spotted fever (1986) (0)
AssociationofAnthracycline-RelatedCardiacHistological LesionsWith NADPHOxidaseFunctionalPolymorphisms (2013) (0)
[The effect of thrombin on platelet membrane glycoproteins measured by lectins]. (1984) (0)
PS1580 PREVALENCE AND RISK FACTORS FOR THROMBOSIS IN ADULT ITP PATIENTS TREATED WITH TPO-RA (2019) (0)
Usefulness and Limitations of Multiple Ligation-Dependent Probe Amplification in Antithrombin Deficiency (2023) (0)
Donor Cell MDS with Rare Complex Karyotype After Mismatch Alobmt for Ph+ALL (2017) (0)
Mutations in the shutter region of anti-thrombin result in severe episodic thrombosis and unlike other serpins in formation of disulfide-linked dimers (2003) (0)
[Half-life of FXIII in vitro after infusion of placental concentrates in a patient with a congenital deficiency]. (1984) (0)
RADIOPROTECTIVE EFFECTS OF FLAVONOIDS AGAINST TO CHROMOSOMAL DAMAGE : RELATION BETWEEN THE STRUCTURE AND ACTIVITY (2004) (0)
C0487: NT-proBNP Provided Complementary Prognostic Information to an Established Clinical Risk Score (CHA2DS2-VASc) for the Prediction of Stroke/Systemic Embolism (2014) (0)
Immunophenotypic Profile and Recurrent Somatic Mutations in 131 Chronic Lymphocytic Leukemia Patients: Low Expression of CD25 in NOTCH1-Mutated Cases (2016) (0)
Abstract P4-07-15: Prognostic impact of miR-18a expression in residual tumor after neoadjuvant chemotherapy for locally advanced breast cancer (2013) (0)
A prognostic model to identify short survival expectancy of medical oncology patients at the time of hospital discharge (2022) (0)
C0405: Role of Syntaxin-11 in Granule Release of Neonatal Platelets (2014) (0)
DNA Repair Genes Transcriptome in Chronic Myelomonocytic Leukemia (2017) (0)
P5829Use of multiple biomarkers to improve CHA2DS2-VASc and HAS-BLED scores in the prediction of thromboembolic and bleeding events (2017) (0)
Anticoagulant therapy in patients with congenital FXI deficiency (2021) (0)
Abstract P5-20-10: Patterns of use and effectiveness of neoadjuvant pertuzumab-containing regimens in stage II-III HER2-neu positive breast cancer: A retrospective, single institutional experience (2018) (0)
Influence of CYP 2 C 19 Polymorphisms in Platelet Reactivity and Prognosis in an Unselected Population of Non ST Elevation Acute Coronary Syndrome (2017) (0)
PROTECTIVE EFFECTS OF SEVERAL PLANT POLYPHENOLS AGAINST CHROMOSOMAL DAMAGE INDUCED IN VIVO BY X-RAYS . COMPARATIVE STUDY VERSUS DIOSMIN AND RUTIN (2005) (0)
Transcriptome of DNA Repair Genes in CMML: Rationale for Targeting ERCC1 and CDKN1A As a Synthetic Lethality Approach (2017) (0)
Plasminogen deficiency in two spanish families response to ddavp administration (1990) (0)
PB1839: INDEPENDENT PROGNOSTIC VALUE OF A PLATELET COUNT OVER 300X109/L IN ACUTE MYELOBLASTIC LEUKEMIA PATIENTS TREATED WITH AN INTENSIVE REGIMEN. (2022) (0)
[Hereditary thrombophilia: learnt lessons and pending duties]. (2007) (0)
PLATELET FUNCTION (PFA-100) AND ACTIVATION IN PATIENTS WITH CHRONIC PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE DISORDERS: ROLE OF THE JAK2 V617F MUTATION (2007) (0)
Homocisteína: factor de riesgo vascular (2003) (0)
Corrigendum to "Generation of induced pluripotent stem cells (iPSCs) from a Bernard-Soulier syndrome patient carrying a W71R mutation in the GPIX gene" [Stem Cell Res. 16/3 (2016) 692-695]. (2016) (0)
TFDP3and DDX53 are Highly Re-Expressed after One Cycle of Azacitidine in Myelodysplastic Syndrome Patients Achieving Complete Response: A Cancer Testis Antigen RNA-Seq Screening (2018) (0)
Persistent Cytotoxic T Lymphocyte Expansions after Allogeneic Hematopoietic Stem Cell Transplantation: Kinetics, Clinical Impact and Absence of STAT3 Mutations (2015) (0)
Comparative assessment of prophylactic transfusions of platelet concentrates obtained by the PRP or buffy-coat methods, in patients undergoing allogeneic hematopoietic stem cell transplantation (2018) (0)
Prognostic and Predictive Effects of Tumor and Plasma miR-200c-3p in Locally Advanced and Metastatic Breast Cancer (2022) (0)
Deubiquitnase BAP1 Downregulation in Myeloid Malignances: A New Pathogenic Mechanism, Dominant in Chronic Myelomonocytic Leukemia (2014) (0)
Predictive value of tumor infiltrating lymphocytes (TIL) for response to breast cancer neoadjuvant chemotherapy (NCT). (2013) (0)
Abstract P5-09-06: Decrease of tumor F3 expression after neoadjuvant chemotherapy associates to lower survival in breast cancer (2015) (0)
C0269: Outpatient Management of Cancer-Related Pulmonary Embolism: Analysis of 562 Consecutive Patients from the Epiphany Study (2014) (0)
[Acquired von Willebrand's syndrome and decrease of factor IX in hypothiroidism (author's transl)]. (1979) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Vicente Vicente?

Vicente Vicente is affiliated with the following schools: